Previous studies have indicated efficacy correlation of CCR8+ Treg cells and CXCL13+ Tex cells with immunotherapy in multiple cancer types;27,28 we therefore matched the infiltration ratio or TCR clonal expansion of CCR8+ Treg cells and CXCL13+ Tex cells with stratified clinical efficacy. Here, CCR8 is linked to cancer.